AstraZeneca Will Now Profit From Covid Vaccine After Pledge To Sell At Cost During Pandemic

The company said it will still sell the jab on a not-for-profit basis to poorer countries.

Source: Forbes.com Healthcare News - November 12, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news